IL1B and colitis: In the same model, the mRNA expression and protein production of NFATc4 increased, while TNF-α and IL-1β expressions (both mRNA and protein) were downregulated by this treatment, thereby preventing weight loss caused by TNBS-induced colitis and improving macroscopic and microscopic scores [14].